Special Opinion on the Assessment of Independent Directors' Independence by the Board of Directors
In accordance with the "Administrative Measures for Independent Directors of Listed Companies" issued by the China Securities Regulatory Commission, the "Stock Listing Rules of the Shenzhen Stock Exchange," and the "Shenzhen Stock Exchange Main Board Listed Company Self-Regulatory Management Guide No. 1 - Norms for Operations," and other relevant laws and regulations, the Board of Directors of Guizhou Xinbang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has assessed the independence of its incumbent independent directors, Mr. Qiu Gang, Mr. Liu Jie, and Mr. Liu Yifeng, and hereby issues the following special opinion:
Upon review of the employment status of independent directors Mr. Qiu Gang, Mr. Liu Jie, and Mr. Liu Yifeng, and their signed self-assessment reports, it is found that the aforementioned individuals do not hold any positions in the Company other than that of independent director, nor do they hold any positions in the Company's major shareholder entities. They have no relationship with the Company and its major shareholders or actual controllers, nor any other relationship that could hinder their independent and objective judgment. This complies with the requirements for the independence of independent directors as stipulated by the "Administrative Measures for Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Main Board Listed Company Self-Regulatory Management Guide No. 1 - Norms for Operations," and other relevant laws and regulations.